Levin Capital Strategies’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-7,597
Closed -$260K 356
2014
Q1
$260K Buy
+7,597
New +$260K ﹤0.01% 295